ProQR Therapeutics N.V. (PRQR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 09:53AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 160.27M |
| Enterprise Value | 54.07M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 22.91 |
| Price/Book (mrq) | 3.62 |
| Enterprise Value/Revenue | 8.30 |
| Enterprise Value/EBITDA | -2.24 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.25 |
| 52-Week Change 3 | -10.05% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 3.2900 |
| 52 Week Low 3 | 1.1100 |
| 50-Day Moving Average 3 | 2.1308 |
| 200-Day Moving Average 3 | 1.7829 |
Share Statistics
| Avg Vol (3 month) 3 | 205.42k |
| Avg Vol (10 day) 3 | 166.22k |
| Shares Outstanding 5 | 81.35M |
| Implied Shares Outstanding 6 | 83.43M |
| Float 8 | 57.49M |
| % Held by Insiders 1 | 18.87% |
| % Held by Institutions 1 | 40.34% |
| Shares Short (Apr 15, 2024) 4 | 241.52k |
| Short Ratio (Apr 15, 2024) 4 | 1.4 |
| Short % of Float (Apr 15, 2024) 4 | 0.42% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.30% |
| Shares Short (prior month Mar 15, 2024) 4 | 272.13k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in EUR.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -280.12% |
Management Effectiveness
| Return on Assets (ttm) | -14.06% |
| Return on Equity (ttm) | -51.33% |
Income Statement
| Revenue (ttm) | 6.59M |
| Revenue Per Share (ttm) | 0.08 |
| Quarterly Revenue Growth (yoy) | 171.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -34.11M |
| Net Income Avi to Common (ttm) | -28.12M |
| Diluted EPS (ttm) | -0.3700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 118.92M |
| Total Cash Per Share (mrq) | 1.46 |
| Total Debt (mrq) | 19.73M |
| Total Debt/Equity (mrq) | 47.68% |
| Current Ratio (mrq) | 3.54 |
| Book Value Per Share (mrq) | 0.51 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 21.55M |
| Levered Free Cash Flow (ttm) | 62.8M |
© 2024 Yahoo. All rights reserved.